Summit Therapeutics
Nasdaq SMMT · Miami, FL
Works in GI & liver · Infectious disease · Oncology · Renal & urogenital · Respiratory · Women's health
Summit Therapeutics is a clinical trial sponsor based in Miami, FL, listed as Nasdaq SMMT. It has 6 active clinical trials with 4,300 planned participants, across 6 therapeutic areas. Since 2021 it has completed 1 trial and stopped 1 early. Its FDA record on file shows 1 inspection.
Trial track record · since 2021
FDA record
Recent FDA actions
Financials · Nasdaq SMMT
Fundraising
Pipeline · 6 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Summit Therapeutics
No warning letter naming Summit Therapeutics is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Summit Therapeutics. The latest inspection ended on 2026-04-10 and was classified NAI (no action indicated). FDA posts a classification after its review, often months after the inspection ended.
Summit Therapeutics is lead sponsor of 6 active clinical trials on ClinicalTrials.gov, with 4,300 planned participants, in GI & liver, Infectious disease, Oncology, Renal & urogenital and other areas. Since 2021 it has completed 1 trial and stopped 1 early.
Summit Therapeutics is based in Miami, FL and is listed as Nasdaq SMMT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Summit Therapeutics; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Summit Therapeutics. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.